Skip to content


Investing in Scientific Discoveries

Leading scientific discoveries requires investing in and supporting early career investigators.

Why it matters:

Since 2004, the ATS Research Program's investment of more than $24M in early career researchers has leveraged well over $880 million in NIH funding and breakthroughs in respiratory medicine.

Investing in early career investigators is crucial for driving advancements in research and transforming patient care. The ATS also emphasizes the importance of cultivating partnerships in business, government, and academia to further support these developments.

The bottom line:

The ATS Research Program is dedicated to advancing scientific discovery and improving patient care in respiratory medicine.